Marathon Partners Equity Management LLC Makes New $6.06 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Marathon Partners Equity Management LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 87,500 shares of the company's stock, valued at approximately $6,055,000. Henry Schein makes up 5.3% of Marathon Partners Equity Management LLC's investment portfolio, making the stock its 6th biggest position. Marathon Partners Equity Management LLC owned about 0.07% of Henry Schein at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Millennium Management LLC raised its position in Henry Schein by 451.7% in the 4th quarter. Millennium Management LLC now owns 497,554 shares of the company's stock worth $34,431,000 after purchasing an additional 407,376 shares during the period. Janus Henderson Group PLC raised its holdings in Henry Schein by 2.7% in the 4th quarter. Janus Henderson Group PLC now owns 10,709 shares of the company's stock valued at $741,000 after acquiring an additional 286 shares during the last quarter. Jefferies Financial Group Inc. increased its stake in Henry Schein by 98.8% during the fourth quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company's stock worth $5,751,000 after acquiring an additional 41,300 shares during the last quarter. Hudson Bay Capital Management LP grew its holdings in shares of Henry Schein by 102.1% in the fourth quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock valued at $101,378,000 after purchasing an additional 740,007 shares in the last quarter. Finally, Humankind Investments LLC lifted its position in shares of Henry Schein by 7.4% during the 4th quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after purchasing an additional 211 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HSIC shares. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company lowered their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Finally, Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Trading Up 2.7%

NASDAQ:HSIC opened at $70.47 on Tuesday. The company has a market cap of $8.58 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50 day simple moving average of $67.57 and a two-hundred day simple moving average of $71.46. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 earnings per share. Research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.